Synthesis and pharmacological screening of several aroyl and heteroaroyl selenylacetic acid derivatives as cytotoxic and antiproliferative agents

Molecules

Volumn 14, Issue 9, 2009, Pages 3313-3338

  Sanmartín, Carmen ^a   Plano, Daniel ^a   Domínguez, Enrique ^a   Font, María ^a   Calvo, Alfonso ^b   Prior, Celia ^b   Encío, Ignacio ^c   Palop, Juan Antonio ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

^c PUBLIC UNIVERSITY OF NAVARRE   (Spain)

Author keywords

Apoptosis; Cytotoxicity; Selenylacetic acid

Indexed keywords

SELENIUM DERIVATIVE;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; DRUG EFFECT; DRUG SCREENING; HUMAN; MALE; SYNTHESIS; TUMOR CELL LINE;

APOPTOSIS; CELL CYCLE; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG EVALUATION, PRECLINICAL; HUMANS; MALE; MODELS, MOLECULAR; MOLECULAR CONFORMATION; SELENIUM COMPOUNDS;

EID: 70349559920     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules14093313     Document Type: Article

References (48)

1. Varmus, H. The new era in cancer research. Science 2006, 312, 1162-1165.
2. Jariwalla, R.J.; Gangapurkar, B.; Nakamura, D. Differential sensitivity of various human tumour-derived cell types to apoptosis by organic derivatives of selenium. Br. J. Nutr. 2009, 101, 182-189.
3. Latreche, L.; Chavatte, L. Selenium incorporation into selenoproteins, implications in human health. In 10th International Symposium on Metal Ions in Biology and Medicine, Bastia, France, 2008; pp. 731-737.
4. Clark, L.C.; Combs, G.F. Selenium-compounds and the prevention of cancer-research needs and public health implications. J. Nutr. 1986, 116, 170-173.
5. Sonn, G.A.; Aronson, W.; Litwin, M.S. Impact of diet on prostate cancer: A review. Prostate Cancer Prostatic Dis. 2005, 8, 304-310.
6. El-Bayoumy, K.; Sinha, R.; Pinto, J.T.; Rivlin, R.S. Cancer chemoprevention by garlic and garlic-containing sulfur and selenium compounds. J. Nutr. 2006, 136, 864S-869S.
7. Gonzalez, C.A.; Salas-Salvado, J. The potential of nuts in the prevention of cancer. Br. J. Nutr. 2006, 96, S87-S94.
8. Sharma, A.K.; Sharma, A.; Desai, D.; Madhunapantula, S.V.; Huh, S.J.; Robertson, G.P.; Amin, S. Synthesis and anticancer activity comparison of phenylalkyl isoselenocyanates with corresponding naturally occurring and synthetic isothiocyanates. J. Med. Chem. 2008, 51, 7820-7828.
9. Sanmartín, C.; Plano, D.; Palop, J.A. Selenium compounds and apoptotic modulation: A new perspective in cancer therapy. Mini Rev. Med. Chem. 2008, 8, 1020-1031.
10. Bardia, A.; Tleyjeh, I.M.; Cerhan, J.R.; Sood, A.K.; Limburg, P.J.; Erwin, P.J. Montori, V.M. Efficacy of antioxidant supplementation in reducing primary cancer incidence and mortality: Systematic review and meta-analysis. Mayo Clin. Proc. 2008, 83, 23-34.
11. Bjelakovic, G.; Nikolova, D.; Simonetti, R.G.; Gluud, C. Systematic review: Primary and secondary prevention of gastrointestinal cancers with antioxidant supplements. Alimen. Pharmacol. Ther. 2008, 28, 689-703.
12. Connelly-Frost, A.; Poole, C.; Satia, J.A.; Kupper, L.L.; Millikan, R.C.; Sandler, R.S. Selenium, folate, and colon cancer. Nutr. Cancer 2009, 61, 165-178.
13. Smith, M.L.; Lancia, J.K.; Mercer, T.I.; Ip, C. Selenium compounds regulate p53 by common and distinctive mechanisms. Anticancer Res. 2004, 24, 1401-1408.
14. Rikiishi, H. Apoptotic cellular events for selenium compounds involved in cancer prevention. J. Bioenerg. Biomembr. 2007, 39, 91-98.
15. Hurst, R.; Elliot, R.M.; Goldson, A.J.; Fainweather-Tait, S.J. Se-methylselenocysteine alters collagen gene and protein expression in human prostate cells. Cancer Lett. 2008, 269, 117-126.
16. Pinto, J.T.; Sinha, R.; Papp, K.; Facompre, N.D.; Desai, D.; El-Bayoumy, K. Differential effects of naturally occurring and synthetic organoselenium compounds on biomarkers in androgen responsive and androgen independent human prostate carcinoma cells. Int. J. Cancer 2007, 120, 1410-1417.
17. Singh, U.; Null, K.; Sinha, R. In vitro growth inhibition of mouse mammary epithelial tumor cells by methylseleninic acid: Involvement of protein kinases. Mol. Nutr. Food Res. 2008, 52, 1281-1288.
18. Poerschke, R.L.; Franklin, M.R.; Moos, P.J. Modulation of redox status in human lung cell lines by organoselenocompounds: Selenazolidines, selenomethionine, and methylseleninic acid. Toxicol. Vitro 2008, 22, 1761-1767.
19. Talas, Z.S.; Ozdemir, I.; Yilmaz, I.; Gok, Y. Antioxidative effects of novel synthetic organoselenium compound in rat lung and kidney. Ecotoxicol. Environ. Saf. 2009, 72, 916-921.
20. Shiah, H.S.; Lee, W.S.; Juang, S.H.; Hong, P.C.; Lung, C.C.; Chang, C.J.; Chou, K.M.; Chang, F.Y. Mitochondria-mediated and p53-associated apoptosis induced in human cancer cells by a novel selenophene derivative, D-501036. Biochem. Pharmacol. 2007, 73, 610-619.
21. Xing, F.; Li, S.L.; Ge, X.Y.; Wang, C.; Zeng, H.H.; Li, D.; Dong, L. The inhibitory effect of a novel organoselenium compound BBSKE on the tongue cancer Tca8113 in vitro and in vivo. Oral Oncol. 2008, 44, 963-969.
22. Barbosa, N.B.D.; Nogueira, C.W.; Guecheva, T.N.; Bellinaso, M.D.; Rocha, J.B.T. Diphenyl diselenide supplementation delays the development of N-nitroso-N-methylurea-induced mammary tumors. Arch. Toxicol. 2008, 82, 655-663.
23. Xiao, H.; Parkin, K.L. Induction of Phase II enzyme activity by various selenium compounds. Nutr. Cancer 2006, 55, 210-223.
24. Rosa, R.M.; Picada, J.D.; Saffi, J.; Henriques, J.A.P. Cytotoxic, genotoxic, and mutagenic effects of diphenyl diselenide in Chinese hamster lung fibroblast. Mut. Res. 2007, 628, 87-98.
25. Zhao, G.H.; Lin, H.K.; Zhu, S.R.; Sun, H.W.; Chen, Y.T. Dinuclear palladium(II) complexes containing two monofunctional [Pd(en)(pyridine)Cl]+ units bridged by Se or S. Synthesis, characterization, cytotoxicity and kinetic studies of DNA-binding. J. Inorg. Biochem. 1998, 70, 219-226.
26. Abele, E.; Popelis, J.; Shestakova, I.; Domracheva, I.; Arsenyan, P.; Lukevics, E. Synthesis and cytotoxicity of di(3-indolyl) selenide derivatives. Khimiya Geterotsiklicheskikh Soedinenii 2004, 6, 868-872.
27. Zeng, H.W.; Briske-Anderson, M.; Idso, J.P.; Hunt, C.D. The selenium metabolite methylselenol inhibits the migration and invasion potential of HT1080 tumor cells. J. Nutr. 2006, 136, 1528-1532.
28. Ohta, Y.; Suzuki, K.T. Methylation and demethylation of intermediates selenide and methylselenol in the metabolism of selenium. Toxicol. Appl. Pharmacol. 2008, 226, 169-177.
29. Plano, D.; Sanmartín, C.; Moreno, E.; Prior, C.; Calvo, A.; Palop, J.A. Novel potent organoselenium compounds as cytotoxic agents in prostate cancer cells. Bioorg. Med. Chem. Lett. 2007, 17, 6853-6859.
30. Plano, D.; Moreno, E.; Font, M.; Encío, I.; Palop, J.A.; Sanmartín, C. Synthesis and biological evaluation of selenadiazole derivatives as anticancer agents. Bioorg. Med. Chem. 2009, (Submitted for publication).
31. De Athayde, P.F.; De Souza, A.G.; De Morais, S.A.; Botelho, J.R.; Barbosa, J.M.; Miller, J.; Lira, B.F. Synthesis and characterization of three new organo-selenium compounds. A convenient synthesis of aroylselenoglycolic acids. Arkivoc 2004, 6, 22-26.
32. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Inmunol. Methods 1983, 65, 55-63.
33. Dong, Y.; Zhang, H.; Hawthorn, L.; Ganther, H.E.; Ip, C. Delineation of the molecular basis for selenium-induced growth arrest in human prostate cancer cells by oligonucleotide array. Cancer Res. 2003, 63, 52-59.
34. Van Brussel, J.P.; Oomen, M.A.; Vosselbeld, P.J.M.; Wiemer, E.A.C.; Sonneveld, P.; Mickisch, G.H.J. Identification of multidrug resistance- associated protein 1 and glutathione as multidrug resistance mechanisms in human prostate cancer cells: chemosensitization with leukotriene D4 antagonists and buthionine sulfoximine. BJU Int. 2004, 93, 1333-1338.
35. Font, M.; Ardaiz, E.; Cordeu, L.; Cubedo, E.; García-Foncillas, J.; Sanmartín, C.; Palop, J.A. Structural characteristics of novel symmetrical diaryl derivatives with nitrogenated functions. Requirements for cytotoxic activity. Bioorg. Med. Chem. 2006, 14, 1942-1948.
36. Accerlys Software Inc. Discovery Studio Modeling Environment Release 1.7. Accerlys Software Inc.: San Diego, USA, 2007.
37. MOPAC MOPAC2009, Stewart, J.P. Stewart Computational Chemistry, Colorado Springs, CO, USA, http://OpenMOPAC.net, 2008.
38. Macrae, C.F.; Edgington, P.R.; McCabe, P.; Pidcock, E.; Shields, G.P.; Taylor, R.; Towler, M.; Van de Streek, J. Mercury: Visualization and analysis of crystal structures. J. Appl. Crystallogr. 2006, 39, 453-457.
39. http://dtp.nci.nih.gov/branches/btb/ivclsp.html, accessed on 27 June 2009.
40. Philchenkov, A.; Zavelevich, M.; Khranovskaya, N.; Surai, P. Comparative analysis of apoptosis induction by selenium compounds in human lymphoblastic leukemia MT-4 cells. Exp. Oncol. 2007, 29, 257-261.
41. Naithani, R. Organoselenium compounds in cancer chemoprevention. Mini Rev. Med. Chem. 2008, 8, 657-668.
42. Fimognari, C.; Nüsse, M.; Cesari, R.; Iori, R.; Cantelli-Forti, G.; Hrelia, P. Growth inhibition, cell-cycle arrest and apoptosis in human T-cell leukemia by the isothiocyanate sulforaphane. Carcinogenesis 2002, 23, 581-586.
43. Mayo, S.L.; Olafson, B.D.; Goddard, W.A. Dreiding: A generic force field for molecular simulations. J. Phys. Chem. 1990, 94, 8897-8909.
44. Viswanadhan, V.N.; Ghose, A.K.; Revankar, G.R.; Robins, R.K. Atomic physicochemical parameters for three-dimensional structure-directed quantitative structure-activity relationships. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally-occurring nucleoside antibiotics. J. Chem. Inf. Comput. Sci. 1989, 29, 163-172.
45. Ghose, A.K.; Viswanadhan, V.N.; Wendoloski, J.J. Prediction of hydrophobic (lipophilic) properties of small organic molecules using fragmental methods: An analysis of ALOGP and CLOGP methods. J. Phys. Chem. A 1998, 102, 3762-3772.
46. 46.Stewart J.J.P.; Optimization of parameters for semiempirical methods V: Modification of NDDO approximations and application to 70 elements. J. Mol. Model. 2007, 13, 1173-1213.
47. Stewart, J.J.P. Optimization of parameters for semi-empirical methods I-Method. J. Comp. Chem. 1989, 10, 209-220.
48. Li, Y.Z.; Pan, J.; Li, J.L.; Lee, J.H.; Tunkey, C.; Saraf, K.; Garbe, J.C.; Whitley, M.Z.; Jelinsky, S.A.; Stampfer, M.R.; Haney, S.A. Transcriptional changes associated with breast cancer occur as normal human mammary epithelial cells overcome senescence barriers and become immortalized. Mol. Cancer 2007, 6, Article 7.